[Studies on the anticoagulant effect of heparin "in vivo" (author's transl)]. 1976

J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
July 1951, American journal of clinical pathology,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
January 1960, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
July 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
December 1950, American journal of clinical pathology,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
January 1981, Masui. The Japanese journal of anesthesiology,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
April 1974, Klinische Wochenschrift,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
October 1975, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
November 1965, The Tohoku journal of experimental medicine,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
January 1978, Arzneimittel-Forschung,
J F Lucia, and L Ercoreca, and J C García Zueco, and F Cinto, and A Raichs
January 1979, Hiroshima Daigaku shigaku zasshi. The Journal of Hiroshima University Dental Society,
Copied contents to your clipboard!